Research programme: ion channel modulators - Dynogen
Alternative Names: Ion channel modulators research programme - Dynogen/NewronLatest Information Update: 05 May 2008
At a glance
- Originator Newron Pharmaceuticals
- Developer Dynogen Pharmaceuticals
- Class
- Mechanism of Action Ion channel modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Gastrointestinal disorders; Genitourinary disorders
Most Recent Events
- 05 May 2008 Discontinued - Preclinical for Gastrointestinal disorders in USA (unspecified route)
- 05 May 2008 Discontinued - Preclinical for Genitourinary disorders in USA (unspecified route)
- 12 Oct 2004 Preclinical trials in Gastrointestinal disorders in USA (unspecified route)